Explained: 2020 Nobel Prize in Physiology or Medicine

Their discovery has helped develop antiviral drugs directed at hepatitis C.

October 05, 2020 04:35 pm | Updated December 04, 2021 11:20 pm IST

Harvey J. Alter, Michael Houghton and Charles M. Rice

Harvey J. Alter, Michael Houghton and Charles M. Rice

The 2020 Nobel Prize in Physiology or Medicine was jointly awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of Hepatitis C virus.

 

What is Hepatitis C virus?

Hepatitis C is a blood-borne virus and causes Hepatitis C disease which affects the liver. According to WHO, “globally, an estimated 71 million people have chronic hepatitis C virus infection and a significant number develop cirrhosis or liver cancer."

In 2016, it was estimated that approximately 3,99,000 people died globally from hepatitis C.

 

How did they discover a new virus?

Harvey J. Alter who was studying hepatitis in patients who had received blood transfusions, found many unexplained infections. Tests for Hepatitis A and Hepatitis B virus infection showed that they were not the cause. His team demonstrated that blood from these patients could transmit the disease to chimpanzees, and more studies showed that an unknown infectious agent was behind this. The mysterious new illness was termed “non-A, non-B” hepatitis.

 

This new virus could not be isolated for several years using the traditional techniques for virus isolation. Michael Houghton and his team created a collection of DNA fragments from the blood of an infected chimpanzee and thoroughly searched it. They found a novel RNA virus belonging to the Flavivirus family and named it the Hepatitis C virus.

To understand if this new virus alone could cause hepatitis, Charles M. Rice used genetic engineering, generated an RNA variant of the virus and injected it into the liver of chimpanzees. The virus was detected in the blood and the chimpanzees exhibited changes similar to those seen in humans with the disease. This was the final proof that the virus alone was the cause behind the unexplained cases of transfusion-mediated hepatitis.

 

Why does this discovery matter?

 

The discoveries by the three Nobel laureates have helped design sensitive blood tests that have eliminated the risk of transfusion-transmitted hepatitis. Their discovery also helped develop antiviral drugs directed at hepatitis C . This has now raised hopes of eradicating the virus from the world population.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.